FDA Clearance Tracker · P250017
GORE® VIABAHN® FORTEGRA Venous Stent
Last checked: Nov 19, 2026Latest source record: Dec 19, 2025 (this decision)Source: openFDAMethods & limitations
Decided
Dec 19, 2025
Approved
Time to decision
182 days
Received Jun 20, 2025. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA
Device class
Class III
The decision
- FDA number
- P250017
- Device name
- GORE® VIABAHN® FORTEGRA Venous Stent
- Applicant
- W. L. Gore & Associates, Inc.
- Applicant location
- Flagstaff, AZ
- Received
- Jun 20, 2025
- Decided
- Dec 19, 2025
- Decision
- Approved
- Supplements
- 3 in FDA's data for this PMA. See them on the FDA record
Device type
- Device type
- Stent, vena cava (QTL)
- Device class
- Class III
- Specialty
- CardiologyInterventional Cardiology
FDA's approval statement
As written in FDA's record.
The GORE® VIABAHN® FORTEGRA Venous Stent is indicated for use in the treatment of symptomatic inferior vena cava obstruction with or without combined iliofemoral obstruction.
How new is this?
These are facts about FDA's records. They are not a judgment about the device.
- This is the earliest decision in FDA's data under product code QTL (Stent, vena cava).
- It is on FDA's public list of Breakthrough Devices with marketing authorization (list dated June 30, 2026).
Source documents
Other decisions for W. L. Gore & Associates, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
- GORE® VIABAHN® VBX Balloon Expandable EndoprosthesisPMA supplement
P160021-S051 · Decided Oct 8, 2026 · 244 days after receipt · Panel Track
Device type: Iliac covered stent, arterial (PRL) · Cardiology
K250410 · Decided Jun 2, 2025 · 109 days after receipt
Device type: Catheter, Percutaneous (DQY) · Cardiology
- GORE TAG Thoracic Branch Endoprosthesis (TBE Device)PMA supplement
P210032-S015 · Decided Apr 11, 2025 · 228 days after receipt · Panel Track
Device type: Endovascular System for Treatment of Ascending Aorta and Aortic Arch Lesions (SDZ) · Cardiology
5 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.